Michelle Caron, Chief Financial Officer at A10 Networks, Inc.. Biography, career history and compensation sourced from SEC proxy filings.
About
Michelle Caron has served as A10 Networks' Chief Financial Officer since September 2025 (effective September 24, 2025). She previously spent roughly 15 years across Danaher Corporation (NYSE: DHR) businesses, serving as Vice President Finance and Chief Financial Officer of Beckman Coulter Life Sciences from June 2021 to September 2025 and as a Global Financial Officer at Pall Corporation from July 2019 to June 2021, and earlier held CFO and finance roles at Phenomenex, Philips Healthcare and Stryker Biotech. A certified public accountant with more than 20 years of finance leadership experience, she holds an MBA from Southern Connecticut State University.
Roles
A10 Networks, Inc.
Chief Financial Officer · Current role
2025–present
Beckman Coulter Life Sciences (a division of Danaher Corporation)
Vice President Finance and Chief Financial Officer
June 2021 – September 2025
Pall Corporation (a subsidiary of Danaher Corporation)
Global Financial Officer – Business Unit (Lab, Food and Beverage, Medical)
July 2019 – June 2021
Phenomenex
Chief Financial Officer · Acquired by Danaher Corporation in 2016.
—
Philips Healthcare
Finance roles
—
Stryker Biotech
Finance roles
—
Fixed Compensation
FY FY2025
Salary
$107,576
ComponentBase salary earned in 2025 (partial year; appointed Sept 2025)
FY2026 base salary$400,000
Bonus
$150,000
ComponentSign-on bonus per offer letter
All other compensation
$2,715
Total compensation
$836,516
Performance Compensation
Data from FY FY2025
Cash incentive
Annual cash incentive
$78,698
FormNon-equity incentive plan
Target Opportunity
—
Target opportunity50% of salary (prorated for time in role)